LianBio Debt Securities, Available-for-sale, Amortized Cost
LianBio (LIANY) had Debt Securities, Available-for-sale, Amortized Cost of $149.08 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2023-11-13
- 2023-09-30: Debt Securities, Available-for-sale, Amortized Cost $149.08M.
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost $163.76M.
- 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost $184.60M.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost $223.98M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2023-09-30 | $149.08M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $163.76M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $184.60M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $223.98M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $234.09M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $196.02M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $230.04M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $155.02M 10-K · filed 2023-03-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |